vs
Goosehead Insurance, Inc.（GSHD）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Goosehead Insurance, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$93.1M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 23.1%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 9.2%）
Goosehead Insurance是一家总部位于美国的个人保险代理机构，提供汽车、房屋、租客、洪水等多类保险产品，与数百家保险商合作，为客户定制高性价比的保障方案，同时通过自营网点和全国特许加盟网络开展业务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GSHD vs PBYI — 直观对比
营收规模更大
GSHD
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出4.6%
23.1%
两年增速更快
PBYI
近两年复合增速
9.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $93.1M | $75.5M |
| 净利润 | $8.0M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 16.1% | 22.7% |
| 净利率 | 8.6% | — |
| 营收同比 | 23.1% | 27.7% |
| 净利润同比 | 204.0% | — |
| 每股收益（稀释后） | $0.19 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GSHDPBYI
| Q1 26 | $93.1M | — | ||
| Q4 25 | $105.3M | $75.5M | ||
| Q3 25 | $90.4M | $54.5M | ||
| Q2 25 | $94.0M | $52.4M | ||
| Q1 25 | $75.6M | $46.0M | ||
| Q4 24 | $93.9M | $59.1M | ||
| Q3 24 | $78.0M | $80.5M | ||
| Q2 24 | $78.1M | $47.1M |
净利润GSHDPBYI
| Q1 26 | $8.0M | — | ||
| Q4 25 | $12.4M | — | ||
| Q3 25 | $7.9M | $8.8M | ||
| Q2 25 | $5.2M | $5.9M | ||
| Q1 25 | $2.3M | $3.0M | ||
| Q4 24 | $14.9M | — | ||
| Q3 24 | $7.6M | $20.3M | ||
| Q2 24 | $6.2M | $-4.5M |
毛利率GSHDPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率GSHDPBYI
| Q1 26 | 16.1% | — | ||
| Q4 25 | 29.4% | 22.7% | ||
| Q3 25 | 23.5% | 17.6% | ||
| Q2 25 | 16.7% | 12.7% | ||
| Q1 25 | 8.8% | 8.7% | ||
| Q4 24 | 29.7% | 22.6% | ||
| Q3 24 | 21.1% | 27.4% | ||
| Q2 24 | 19.7% | -4.6% |
净利率GSHDPBYI
| Q1 26 | 8.6% | — | ||
| Q4 25 | 11.8% | — | ||
| Q3 25 | 8.7% | 16.2% | ||
| Q2 25 | 5.5% | 11.2% | ||
| Q1 25 | 3.1% | 6.5% | ||
| Q4 24 | 15.8% | — | ||
| Q3 24 | 9.7% | 25.2% | ||
| Q2 24 | 7.9% | -9.6% |
每股收益（稀释后）GSHDPBYI
| Q1 26 | $0.19 | — | ||
| Q4 25 | $0.48 | $0.26 | ||
| Q3 25 | $0.29 | $0.17 | ||
| Q2 25 | $0.18 | $0.12 | ||
| Q1 25 | $0.09 | $0.06 | ||
| Q4 24 | $0.58 | $0.40 | ||
| Q3 24 | $0.29 | $0.41 | ||
| Q2 24 | $0.24 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $25.7M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $-121.3M | $130.3M |
| 总资产 | $392.8M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GSHDPBYI
| Q1 26 | $25.7M | — | ||
| Q4 25 | $34.4M | $97.5M | ||
| Q3 25 | $51.6M | $94.4M | ||
| Q2 25 | $92.4M | $96.0M | ||
| Q1 25 | $70.2M | $93.2M | ||
| Q4 24 | $54.3M | $101.0M | ||
| Q3 24 | $47.5M | $96.7M | ||
| Q2 24 | $23.6M | $96.8M |
总债务GSHDPBYI
| Q1 26 | — | — | ||
| Q4 25 | $289.5M | $22.7M | ||
| Q3 25 | $290.0M | $34.0M | ||
| Q2 25 | $289.8M | $45.3M | ||
| Q1 25 | $290.3M | $56.7M | ||
| Q4 24 | $82.3M | $68.0M | ||
| Q3 24 | $84.6M | $79.3M | ||
| Q2 24 | $87.0M | $90.7M |
股东权益GSHDPBYI
| Q1 26 | $-121.3M | — | ||
| Q4 25 | $-95.5M | $130.3M | ||
| Q3 25 | $-105.0M | $115.3M | ||
| Q2 25 | $-78.6M | $104.7M | ||
| Q1 25 | $-88.5M | $97.1M | ||
| Q4 24 | $43.9M | $92.1M | ||
| Q3 24 | $58.3M | $71.1M | ||
| Q2 24 | $39.8M | $48.5M |
总资产GSHDPBYI
| Q1 26 | $392.8M | — | ||
| Q4 25 | $414.9M | $216.3M | ||
| Q3 25 | $403.6M | $202.9M | ||
| Q2 25 | $436.6M | $194.9M | ||
| Q1 25 | $412.6M | $196.2M | ||
| Q4 24 | $397.7M | $213.3M | ||
| Q3 24 | $358.1M | $220.7M | ||
| Q2 24 | $338.2M | $205.0M |
负债/权益比GSHDPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 1.87× | 0.74× | ||
| Q3 24 | 1.45× | 1.12× | ||
| Q2 24 | 2.19× | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流GSHDPBYI
| Q1 26 | — | — | ||
| Q4 25 | $91.8M | $14.4M | ||
| Q3 25 | $24.2M | $9.7M | ||
| Q2 25 | $28.9M | $14.1M | ||
| Q1 25 | $15.5M | $3.6M | ||
| Q4 24 | $71.5M | $15.6M | ||
| Q3 24 | $28.1M | $11.0M | ||
| Q2 24 | $18.9M | $1.0M |
自由现金流GSHDPBYI
| Q1 26 | — | — | ||
| Q4 25 | $86.1M | $14.4M | ||
| Q3 25 | $23.7M | $9.7M | ||
| Q2 25 | $27.2M | $14.1M | ||
| Q1 25 | $14.9M | $3.6M | ||
| Q4 24 | $70.6M | $15.6M | ||
| Q3 24 | $28.0M | $11.0M | ||
| Q2 24 | $18.6M | $1.0M |
自由现金流率GSHDPBYI
| Q1 26 | — | — | ||
| Q4 25 | 81.8% | 19.1% | ||
| Q3 25 | 26.2% | 17.7% | ||
| Q2 25 | 28.9% | 26.8% | ||
| Q1 25 | 19.7% | 7.7% | ||
| Q4 24 | 75.1% | 26.4% | ||
| Q3 24 | 35.9% | 13.7% | ||
| Q2 24 | 23.9% | 2.1% |
资本支出强度GSHDPBYI
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | 0.0% | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 1.8% | 0.0% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 1.0% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.3% | 0.0% |
现金转化率GSHDPBYI
| Q1 26 | — | — | ||
| Q4 25 | 7.38× | — | ||
| Q3 25 | 3.06× | 1.10× | ||
| Q2 25 | 5.61× | 2.41× | ||
| Q1 25 | 6.61× | 1.21× | ||
| Q4 24 | 4.82× | — | ||
| Q3 24 | 3.72× | 0.54× | ||
| Q2 24 | 3.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GSHD
| Renewal Royalty Fees (2) | $43.6M | 47% |
| Renewal Commissions (1) | $18.2M | 20% |
| Contingent Commissions (1) | $10.7M | 11% |
| New Business Royalty Fees (2) | $7.9M | 8% |
| New Business Commissions (1) | $7.5M | 8% |
| Other | $3.7M | 4% |
| Initial Franchise Fees (2) | $1.6M | 2% |
PBYI
暂无分部数据
